DatasetName,NECTIN2_S(430) NECTIN2_S(433) NECTIN2_S(517) NECTIN2_S(520) NECTIN2_S(524) NECTIN2_T(387) NECTIN2_T(426) NECTIN2_T(459) NECTIN2_Y(454) NECTIN2_Y(513),NECTIN2_T(390) NECTIN2_T(410) NECTIN2_Y(406) NECTIN2_Y(518)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5299878084309444,
SR2019_MCF7_Biol_repl_3,,0.5971983257818152
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,0.5489930887345116
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5157279068487759,0.5377546064607828
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,0.5537627200376173,0.5324644328523954
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5343989290718201
HS2024_6_B_T3,0.5354232850144066,0.5835179493527713
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,0.5566509480156865
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5295263179011664,
SR2019_MDAMB231_Biol_repl_4,,0.6035733039646693
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,0.5361078332260208,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5280042674164172,0.5384616051351944
FSO2013_Ratio M/L normalized Rep1___1,0.529499496193468,
SAS2015_AZD/DMSO_Exp3,0.5368945894338458,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,0.545051997166112
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5295948055664733,0.5989883791548272
WZ2023_Pu_010_30min,0.5257117023969256,0.5682572064284915
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.4973158221324657,0.5386483972777909
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5264538360716184,0.5695793346146598
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.5271754332944308,0.5346571229287368
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,0.5351934793817584,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5261891741777227,0.5316515889803546
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,0.5365638401801617,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5349139535709643
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5319252400737196,0.5671913686653526
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.5237839552358091,0.5687131294100036
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.5661218925355944
WZ2023_Pu_025_30min,0.5260023540455607,0.5722076474145191
AH2018_SILAC_MR_2_X,0.5022051144461084,0.5438743652695788
HS2024_4_PD_T2,0.5371647943355581,0.543161412720005
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,0.5614570645069049
CR2017_Ratio Replicate 1.4,,0.5273904819444439
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.5943383399835472
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5094614381865921,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5168428055205343,
HS2024_7_PD_T2,0.5127668715733223,0.5681996318321905
FSO2013_Ratio H/L normalized Rep1___1,0.5323908528569257,
AH2018_LFQ_1_C,0.5054991984296731,0.5501702825652043
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.5289158723572397,0.5438215211046006
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5329188312488934,0.570896001563049
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5145129932142782,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5225407712091967,0.6086562097801437
FSO2013_Ratio H/L normalized Rep2,0.530796164589014,
WZ2023_Pu_005_20min,0.5265339574489947,0.5671395717728974
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5609422317567466
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5167294590557738,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5019197096350563,0.557406047883527
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5350419145614611,0.6015375082739558
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5486370638912035,0.5580085937881658
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,0.5725580440738572
RCJD2014_20min_mean,0.5806809437530251,0.5848797836407506
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.49473194950114047,0.5547669307589125
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,
PG2020_Intensity Mock_10h_D,0.5148008268299444,0.5368057678220163
SR2019_MCF10A_Biol_repl_2,,0.5639603430380851
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5209835199140442,0.5923794777252049
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5169814869931211,0.5599958762473234
RCJD2014_5min_1,0.49214726181255913,0.5516913517577741
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,0.5365554056170099,
SAS2015_PLX/AZD_Exp2,0.5307723078741186,
CR2017_Ratio Replicate 3.3,,0.5639615747790111
PG2020_Intensity 2h_C,0.5165432647470907,0.5558831331112392
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5338700316628047
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5340250979610663,0.6141394929390529
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,0.5510454122220747
HS2024_5_PD_T1,0.5377759032345719,0.5378255302838195
AH2018_LFQ_M_2_C,0.4864365943456752,0.5453234832063565
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5082608618341331,
YA2020_Reporter_intensity_Cancer_No.5,,0.5999473502106776
HH2022_Reporter intensity 8,0.5148158714236409,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.4973007332396816,0.5254784335211563
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5315501332726811,0.6175429372542905
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5133866058010703,
YA2020_Reporter_intensity_Normal_No.1,,0.5920473990517807
HS2024_3_B_T1,0.5653621860129113,0.5519010132138596
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,0.5575409404060323
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5407913078822622
SR2019_Hs578T_Biol_repl_3,,0.5804159107690183
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,0.546878461837671,0.5192438696310135
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5302181805027911,0.6021216823737348
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.526979055838469,0.5732338708345834
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5224033023533069,0.49796417877064986
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,0.5288779108833244,
RAM2015_Log2 A,,
HS2024_8_PD_T1,0.5444843417737937,0.5700203103571957
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5127107699816225,
KS2014_Intensity E15_2,0.5227925559881064,0.6160239337692184
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.496250617993648,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.4911034824483485,0.5691201762731134
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5243079637889193,0.5363992754717919
AH2018_SILAC_M_3_X,0.5106126032416147,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5380507575887032
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5297892425832581,0.5995004955836297
HS2024_6_B_N1,0.5128404014546053,0.5452975787593388
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5130313803579225,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.503865754101606,0.5626416555858857
FSO2013_Ratio M/L normalized Rep2,0.5390980184932126,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5192202314332331,
SR2019_HCC1954_Biol_repl_2,0.5170059016815284,0.5966963239374252
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5426717405368653
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5552108946888963
DL2023_control-1,,
AR2021_ALG 10 μM,0.510141601524901,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5115189710904489,
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5307548570253005,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5214903497548778,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5160403385032738,
CK2022_11 200-1,,
CK2022_12 200-1,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.527597442272834,0.5673988463621535
AH2018_TMTMS2_2_N,0.5341364168815559,0.5669726714469978
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5021942857923586,0.5383875026361467
KS2014_Intensity N4,0.5248350413477129,0.563536487499632
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5109098931108085,0.5615122770634463
CK2022_14 200-1,,
SR2019_Hs578T_Biol_repl_1,,0.5764478138536975
RB2022_7_PostSprint,,
TM2022_mock.4h.A,0.5345602125267442,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.507628417186627,0.5506291186634219
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5251555277273616,0.545188328769475
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,0.5756037169264939
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.5063100619775358,0.5622519960953847
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5305609774389084,0.5705413649728548
CF2017_EOC 1,,0.5076337987992579
CK2022_3 200-1,,
AH2018_LFQ_IT_3_C,0.5179278313186165,
SR2019_Hs578T_Biol_repl_2,,0.579818435902882
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5319515534846632,0.5212673670392951
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5196334372334468,0.6197809953044353
HS2024_5_B_T1,0.5139271492927202,0.560670657571638
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,0.6063198840283236
HS2024_3_B_T2,0.53946271504367,0.5491299195658381
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,,
JW2021_Before_2,,
TM2022_S2.12h.A,0.5356913360363369,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.5595361148058857,0.5474972429260148
HS2024_4_B_T1,0.47237803287873825,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,0.5697281500517206
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5834560633711605,0.5664048441093171
CR2017_Ratio Replicate 3.2,,0.5325544397099858
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,0.5624141211807383
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.5303289830696261
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5246862193208462,0.5668564605374176
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5145635969645043,
HS2024_5_PD_T3,0.524854443287925,0.5632517953263423
AH2018_TMTMS3_3_X,0.5051665587732604,0.544897056313074
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.5021020338846872,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,0.5591404638243874
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.5845208698402922
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5445907485691934
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,0.5527668572374348
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.555160036953529,0.5785616484983077
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5354958793154528,0.5852819944010144
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5315408464569062,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,0.545128237438975
LY2019_P3+,,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.5398754428601787,0.6078754766109716
AH2018_TMTMS2_3_X,0.532033119294195,0.5676256015821338
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5330876665643423,0.5831439296126665
RM2024_Intensity D0-1___2,,0.5657362542171862
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5947572190989585
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5295171432573507,0.583795394929539
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,0.5362347096416726,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5384840932282852,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.5781067198265606
HS2024_8_B_T2,0.5108088743263627,0.5743535442246154
AH2018_LFQ_1_X,,0.5272844948409581
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.4797244357270067,0.5221239890620055
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.526098559107991,0.551282974507305
HH2022_Reporter intensity 1,0.5304794311691217,
HH2022_Reporter intensity 2,0.5317002741213928,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,0.5635191981944163
YA2020_Reporter_intensity_Normal_No.5,,0.5871263469477578
SR2019_MCF7_Biol_repl_1,,0.591005306380628
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5311632168331758,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5290737630745483,0.5190678040806127
SR2019_LM2_Biol_repl_3,,0.5998509848975585
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.5865677965897194
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5155708373782872,
AR2021_KD 72h,0.48539214463163416,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5045562565596385,0.5349948183252485
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.514198622290549,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,0.5558143553455831
SR2019_SKBR3_Biol_repl_1,,0.5841678181475282
PG2020_Intensity Mock_10h_C,0.5091094982479948,0.5340797345984847
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5466349212319952,0.562630371637624
PG2020_Intensity 10h_A,,0.5592552050130605
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5130865519978862,
SAS2015_PLX/AZD_Exp1,0.5504770287383373,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5406171102261434,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,0.5348772814006972,
RN2012_L15,,
KS2014_Intensity pY_PV3,0.52522504675522,
TM2022_S2.4h.B,0.5359392457417197,
PG2020_Intensity 4h_A,0.5052785727380008,0.5120554498802943
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,0.5374822959331917,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5282047951052782,0.577909249760948
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5113409092088045,0.5503729659530324
CK2022_7 200-1,,
CK2022_5 200-1,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.531117050001934,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5058731567925376,0.5363205068756232
AH2018_SILAC_MR_1_X,0.5092668634115769,0.5435262933206768
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,0.5452351796898491
RM2024_Intensity D4-1,,0.555771049247959
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5131004564060289,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5394421181344828,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,0.5901426397377583
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5111217107490564,
SAS2015_PLX/DMSO_Exp1,0.5467848018805054,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.5295450315242229,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,0.5561761971661565
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5336412194502349,0.5396805396614726
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.507746807152717,
AH2018_SILAC_IT_1_X,0.5146709570540217,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.521211783815174,0.5802943794671889
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.528413574113989,0.5650294379758249
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5111668942764946,0.535351510991702
HS2024_4_I_N2,0.5031665571393261,0.5671011574551208
AH2018_TMTMS2_3_N,0.5345049216645521,0.5655304220790343
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.4596612530310421,0.5722905737836209
WZ2023_Su_005_30min,0.5297241914085492,0.5728395919038025
SR2019_HCC1419_Biol_repl_4,0.5387090908669945,0.6120563231316992
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5050709433272649
WZ2023_Su_025_10min,0.5193952991075513,0.5615648257668939
AH2018_LFQ_IT_4_X,0.5094095737088666,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5241219725236415,0.5665305200243196
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5329529534990364,0.5558295232628646
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5201932239645289,0.5710126658945313
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5518518040597755
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.5178985024770123,0.5150060548113501
RN2012_L10,,
PG2020_Intensity 4h_C,0.5230963868047029,0.5225942764214347
EP2017_Mitotic R#3 normalized log2 ratio,0.5204891241119505,0.5395738552593293
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5116208145730388,
HS2024_4_B_T3,0.5060079437453131,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.49020041620223764,0.5812466413151406
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5493437490295234,0.6000649727853153
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.554837279376062
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5108099685461349,0.5567164595324913
GF2025_P9_Sph,,
CK2022_6 200-1,,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5123376681869092,0.5341406202876755
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.5957937430303185
HS2024_4_I_T2,0.5226334959698102,0.5289045593676551
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5158042868458838,0.5564001683390041
SAS2015_AZD/DMSO_Exp1,0.5252145999196345,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,0.5541160022602714
HS2024_3_B_T3,0.5290690919214388,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.5205445196198724,0.6051106322138502
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.5383382982607043
EP2017_Untreated R#3 normalized log2 ratio,0.5248434488489306,0.5909789916292723
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5885611894769002
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,0.5346486254209515,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5153913169361402,0.5308669943677324
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,0.5530795163905349
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5179167381499553,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5282211447690032,0.5703542622341683
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.5002775211696383,0.5542098030764652
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5176122715945229,0.5524915231778468
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.5402378667579203,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5273097601645298,0.5437673022574513
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5179410834053012,
PG2020_Intensity CT_C,,0.5507244891657365
ZCP2016_Ratio H/L Rep 1,0.5161280334717249,0.5381048681588113
FS2019_db/db2,,
KS2014_Intensity pY_PV4,0.5217964257345253,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5250461495327087,0.5911521115164178
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.6000189888298102
HS2024_8_PD_T2,0.5316367108483016,0.5466370160735038
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5363224485299736,0.5906048061404109
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.5431494045372338,0.504308120683602
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.5862159603379546
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,0.5854954223177022
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5322658953181783,0.5157594802802998
HS2024_3_PD_T3,0.548644198908085,0.5519535081416507
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5157834508175386,0.5448146831944927
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5411795043424025,0.5799801040142185
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5286057547582269,0.5589708239503227
PG2020_Intensity Mock_10h_B,0.5181036094353857,0.5547562096749072
WZ2023_Su_025_30min,0.5248745785696196,0.5607635905536923
AH2018_LFQ_4_N,,0.5495554529424511
CR2017_Ratio Replicate 1.2,,0.5365875765485992
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.48696545349934456,0.5846347837292013
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5061530986535211,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5744085860617855,0.5354919568839828
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5118428091108945,0.5471503714390751
SR2019_Hs578T_Biol_repl_4,,0.5760507379248414
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.528608751550435,0.5662988181458444
RM2024_Intensity D0-1,,0.5593754357917409
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,0.536684122806365,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.49330799188673524,
SR2019_BT549_Biol_repl_1,,0.5664452110611555
AH2018_LFQ_M_4_N,0.5099097302757196,0.5570409506128116
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,0.5543857532915432
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5227353722676105,0.6094337909945867
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5113467344302456,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.6108043821948318
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,0.5519715278510803
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,0.5582742591059415
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5006934834801197,0.5554849944175956
RKK2015_TNF-α/IKKb,0.5565384639653959,0.5462311358021513
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5545281425391868
SR2019_BT549_Biol_repl_2,,0.5594763356646596
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.54146898831071,0.6145001687970327
WZ2023_Su_025_20min,0.5219507905239038,0.5632133258829393
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,0.558215013339019
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5297781157568163,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.5546087118092691
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5184251643681166,0.561123131902326
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5246289532798656,0.5277591472341536
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5190672126364735,0.5066440134884828
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5094715749624862,0.5408520072611164
AH2018_LFQ_M_4_C,,0.5622852980255566
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5316345677536848,0.5684336998979939
HS2024_8_PD_T3,0.5461444571831332,0.5471361568021773
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5144658246700925,0.5516273797225331
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5279587288141212,0.5695374770351436
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,0.5958233750140689
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5557405688615087,0.6007483257228634
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5357726950911339,0.565353143385853
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5045078730610597,0.5422411390978007
HS2024_8_I_N2,0.5100629669175022,0.6109791943258882
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.5895573745517417
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5480503411178167
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.512394786783321,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5323676528622421,0.569765494051754
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5152600455864742,0.5387915592277362
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5461252940805622,0.5636669226065006
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,0.5134934290163754,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5646768508391347
HS2024_5_B_T2,0.5241588076926669,0.5632488576660325
HS2024_6_I_T1,0.5315775134325367,0.536167880278682
HS2024_5_B_T3,0.5603932685576817,0.5217216355053806
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5033997295409061,0.5405321534236976
SR2019_HCC1419_Biol_repl_2,0.5414184592788105,0.614836017136086
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5263001394607842,0.5444929014098141
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5250685089530807,0.5451213399114658
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5250043516311604,0.5643248205814133
KS2014_Intensity C2,0.5259095711640212,0.5764346218720104
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,0.5540080198096565
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.4991802750139273,0.5761141835084224
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,0.5000770137261931,0.5522340693304484
RKK2015_TNF-α/TNF-α+SC-514,0.5532130068407561,0.5341162542137147
CR2017_Ratio Replicate 2.5,,0.622043377258214
HS2024_3_I_T3,0.5595053417720528,0.6002913487376692
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5266592347762495,0.6032897811552408
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5180934988889176,0.5152332997619069
RKK2015_SC-514/basal,0.5463687791811102,0.5810701521419177
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5233344995854521,0.5623909047536606
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5545438523058093,0.5391106961165094
KS2014_Intensity N1,0.5217548496148083,0.5838360996510997
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,0.5359475825474684,
CR2017_Ratio Replicate 1,,0.5243994338051184
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5261616065418548,0.5215949993042576
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5030194377149674,0.5571932777153678
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5268337662505994,0.5484888867355745
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.5802844421471123,0.5387069260301702
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5113044394501315,0.584300428085159
HS2024_5_I_N1,0.5051298555147113,0.5649055552995572
HS2024_6_I_N1,0.5254913122359068,0.5221462085785415
AR2021_KD 48h,0.4997028490646048,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5634520666057667,0.5445038550803925
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,0.6015775590514552
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.5227290087097654,0.6051831605021665
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5332095711329045,0.5683568280837882
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5317811696597697,
AH2018_LFQ_M_2_X,0.5117816002524939,
AH2018_LFQ_IT_4_N,0.5133861238388013,
CK2022_15 200-1,,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5256052687491921,0.5652570223083918
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5336305269568181,0.5592637366089137
HS2024_8_B_T3,0.5223946357050457,
YA2020_Reporter_intensity_Cancer_No.3,,0.5862602368690687
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.534634859990525,0.5713343673403922
KS2014_Intensity pY_C6,0.5157688700091138,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5716919577950241,0.58240284934671
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5832478495490461,0.5626685719094591
KS2014_Intensity C1,0.5264233549006109,0.5773847202314972
FSO2013_Ratio H/M normalized Rep3___1,0.5158997324180093,
AH2018_SILAC_M_3_C,0.5139925302669597,
RKK2015_TNF-α+IKKb/TNF-α,0.5182145348881955,0.5692205108235286
RM2024_Intensity D0-3___2,,0.5647518163519919
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5186592215899961,
AH2018_SILAC_M_2_X,0.5141845952442381,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5263912361819061,0.5648141800702359
PG2020_Intensity 6h_C,,0.5247947657999903
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.48055200371289136,0.5621494067946244
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5380435442572394,0.5726238304524989
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,0.5244976266585402,
HS2024_3_I_N2,0.547380023942688,0.5436122943616666
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5385137927165004,
IMM2018_normalised rep. int. CDK5L-1,,0.5531869069207903
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5149835009365294,0.5606054738665595
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5110974850480828,
AR2021_L41 10 μM,0.4998529216766038,
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5171936311633425,0.5502116683935794
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,0.5336512340592343
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,0.5339114792075891,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5318371512296094,
RM2024_Intensity D2-2___2,,0.559173725184396
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.530761446977865,0.5642655053360421
AR2021_L41 1 μM,0.5222713455127207,0.5770967994795235
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5369758948235982,0.5811471999450886
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5329172682492416
KS2014_Intensity C4,0.5243520064875303,0.599980315013659
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.502510464439455,0.5446387390524245
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.5683664000057476
HS2024_7_B_T2,0.5046674541771761,
SAS2015_PLX/DMSO_Exp3,0.5520781283636784,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.49686145845513935,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5980771128700668
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5202278292870206,
WZ2023_Pu_025_10min,0.5248942247491989,0.5674642187004801
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5316634700956623,0.599351028520933
FSO2013_Ratio M/L normalized Rep3___1,0.5295432510943254,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.5424163981746141,0.6018563355768337
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.532010924173181,0.5660005029660738
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5160621614270452,
KS2014_Intensity C6,0.5274466141695645,0.6000227200366002
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5355713312870771
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5179238409686376,
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5034689806744311,0.5500708429515397
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5298982599816675,
SR2019_HCC1954_Biol_repl_3,0.5173702943760419,0.6000413150712135
CR2017_Ratio Replicate 2.2,,0.5846229225683715
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.6034247417265483
PG2020_Intensity CT_B,0.4933970756276123,0.5490274895963816
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.527116840800276,0.5452897536437444
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5149808311600613,0.5837521296323163
AH2018_LFQ_3_C,0.4815541142968958,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.49157723285462174,0.5571495517287639
YA2020_Reporter_intensity_Cancer_No.4,,0.6000573575249128
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5107899223382102,0.5665915634853083
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5204187961243867,0.5632674783755037
AH2018_TMTMS2_1_X,0.5301821584278222,0.5770670502192428
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.5439515366458508,0.5466836486742654
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.5173111656709719,0.5376986142936072
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,0.5344759678801991,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.46375981536656125,0.5792337951555988
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5098134960750874,0.5794322056668658
HS2024_4_I_T3,0.5194533852597228,0.5388974915630913
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,0.5569116757282806
AH2018_TMTMS3_1_X,0.5144124380574336,0.5576482214051935
CF2017_FTE 14,0.5165061207417196,0.5723509658813257
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5515145151510964,0.5537264571763243
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,0.539350785593373,0.6145920125859243
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5287704257793608,0.5189075158113778
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.515361710473133,0.5976798619893107
SAS2015_PLX/AZD_Exp3,0.5396300518131614,
EP2017_Pervanadate R#2 log2 ratio,0.513847144542043,0.5270118200127126
AS2011_Ratio H/L Normalized RNAi_2_1,,
